TRML

Tourmaline Bio Inc. (TRML)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 1.23B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 47.75
52W Low
$ 11.56
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
24.6552
200-Day MA
19.0704
52 Week High
47.75
52 Week Low
11.56

About TRML

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Employees
76
Headquarters
New York, NY
CEO
Dr. Sandeep C. Kulkarni M.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg